- Home
- ANIX vs FORA Comparison
ANIX vs FORA Comparison
Compare ANIX & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- FORA
- Stock Information
- Founded
- ANIX 1982
- FORA 2014
- Country
- ANIX United States
- FORA United States
- Employees
- ANIX N/A
- FORA N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- ANIX Health Care
- FORA Technology
- Exchange
- ANIX Nasdaq
- FORA Nasdaq
- Market Cap
- ANIX 95.7M
- FORA 69.4M
- IPO Year
- ANIX 1987
- FORA N/A
- Fundamental
- Price
- ANIX $4.10
- FORA $2.12
- Analyst Decision
- ANIX Strong Buy
- FORA Strong Buy
- Analyst Count
- ANIX 3
- FORA 1
- Target Price
- ANIX $9.00
- FORA $5.00
- AVG Volume (30 Days)
- ANIX 282.6K
- FORA 378.3K
- Earning Date
- ANIX 09-10-2025
- FORA 11-12-2025
- Dividend Yield
- ANIX N/A
- FORA N/A
- EPS Growth
- ANIX N/A
- FORA N/A
- EPS
- ANIX N/A
- FORA N/A
- Revenue
- ANIX N/A
- FORA $25,031,040.00
- Revenue This Year
- ANIX N/A
- FORA $47.82
- Revenue Next Year
- ANIX N/A
- FORA $10.11
- P/E Ratio
- ANIX N/A
- FORA N/A
- Revenue Growth
- ANIX N/A
- FORA 18.59
- 52 Week Low
- ANIX $2.07
- FORA $1.64
- 52 Week High
- ANIX $4.98
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- ANIX 56.53
- FORA 44.99
- Support Level
- ANIX $4.21
- FORA $2.21
- Resistance Level
- ANIX $4.67
- FORA $2.62
- Average True Range (ATR)
- ANIX 0.34
- FORA 0.12
- MACD
- ANIX 0.04
- FORA -0.02
- Stochastic Oscillator
- ANIX 50.67
- FORA 5.62
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.